Development & validation of stability indicating method for quantification of nebivolol & their related substances by HPLC-UV-PDA detection in its pharmaceutical drug product

International Journal of PharmTech Research

Volumn 1, Issue 4, 2009, Pages 1139-1147

  Mehta, Jigar ^a   Vyas, N G ^a  

^a Cadila Pharmaceutical Ltd   (India)

Author keywords

Degradation; HPLC; Nebivolol; Related substances; Validation

Indexed keywords

ACETONITRILE; BUFFER; DILUENT; EXCIPIENT; NEBIVOLOL;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IMPURITY; DRUG STABILITY; DRUG STRUCTURE; ELUTION; FLOW RATE; ISOMER; PRACTICE GUIDELINE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; TABLET FORMULATION; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 77953388397     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ICH Guideline Q3A (R2), Impurities in New Drug Substances, October 25, 2006.
2. ICH Guideline Q7A, Good Manufacturing Practice Guide for Active pharmaceutical Ingredients, November 2005.
3. Van de Water, A., Xhonneux, R., Reneman, R., & Janssen, P. (1988) Eur. J Pharmacol. 156, 95-103
4. Broeders, M.A., Doevendans, PA., Bekkers, B.C., Bronasaer, R., Gorsel, E., Heemaskerk, J.W, Egbrik, M.G, Breda, E., Reneman, R.S., & Zee, R. (2000) Circulation 102, 677-684
5. Pauwels, P, Gommeren, W., Lommen-van, G., Janssen, P, & Leysen, J. (1998) J. Mol. Pharmacol. 34, 842-851
6. Xhonneux, P., Wouters, L., Reneman, R., & Janssen, P (1990) Eur. J Pharmacol. 181, 261-265
7. Cockcroft, J. (2004) Expert Opin. Pharmacother 5, 893-899
8. Cockcroft, J.R., Chowienczyk, P.J., Brett, S.E., Chen, C.P, Dupont, A.G., Nueten-van, L., Wooding, S.J., & Ritter, J.M. (1997) J Pharmcol. Exp. Ther 274, 1067-1071
9. McNeely, W., & Goa, K.L. (1999) Drugs 57,633-651
10. J. Hendrickx, M. Bockx, C. Zwijsen, C. Borgmans, G. Mannens, W. Meuldermans, J. Heykants; Journal of Chromatography A, Volume 729, Issues 1-2, 5 April 1996, Pages 341-354
11. N.V.S. Ramakrishna, K.N. Vishwottam, M. Koteshwara, S. Manoj, M. Santosh, D.P. Varma; Journal of Pharmaceutical and Biomedical Analysis, Volume 39, Issue 5, 4 October 2005, Pages 1006-1013
12. LJ Patel1, BN Suhagia2, PB Shah1, Ind. Jou.phar.sci.;volumn69, issue 4, 2007, 594-596
13. S. Görög, M. Babják, G. Balogh, J. Brlik, A. Csehi, F. Dravecz, M. Gazdag, P. Page 16 of 26 Accepted Manuscript 16 Horváth, A. Laukó, K. Varga, Talanta 44 (1997) 1517-1526.
14. S. Görög, TRAC-Trends Anal. Chem. 22 (2003) 407-415.
15. Satinder Ahuja, Henrik Rasmussen, HPLC Method Development for Pharmaceuticals, 2007